Institutional investors hold a majority ownership of AGN through the 86.97% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2018, these large investors purchased a net $8.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORGES BANK INVESTMENT MANAGEMEN... Bought 3.6 Million shares of Allergan plc
TIAA-CREF INVESTMENT MANAGEMENT ... Bought 1.9 Million shares of Allergan plc
CLEARBRIDGE INVESTMENTS LLC Bought 1.8 Million shares of Allergan plc